Literature DB >> 7708256

Progression of renal failure in the Han: SPRD polycystic kidney rat.

M Zeier1, G Pohlmeyer, F Deerberg, R Schönherr, E Ritz.   

Abstract

The Han: SPRD Pkd rat mutant is an autosomal dominant rat model with incomplete penetration of polycystic renal transformation. Progressive renal failure occurs in heterozygous male animals. The mechanisms of progression have not been elucidated. To identify some pathogenetic factors involved we subjected male SPRD Pkd rats (and their non-affected littermates as controls) to uninephrectomy (UNX), castration or enalapril treatment. To assess progression S-urea at age 150 days was chosen as endpoint. (i) In uninephrectomized male Han: SPRD Pkd (n = 12 animals per group) S-urea at age 150 days was consistently above 300 mg/dl, while it was 245 mg/dl (191-290) in control Han: SPRD Pkd. (ii) In castrated male Han: SPRD median S urea at 150 days was 100 mg/dl (69-211) compared to sham-operated male Han: SPRD controls (245; 191-290). Castration did not, however, prevent accelerated progression after uninephrectomy. (iii) Enalapril (50 mg/l) in the drinking fluid did not significantly lower median systolic blood pressure (by plethysmography) in animals on 0.2% sodium diet (at 185 days 160 mmHg; 140-170 versus 170; 140-195 in non-enalapril controls), although circulating ACE was significantly inhibited (17 U; 11-33 versus 89; 52-108 in controls). S-urea at age 185 days was not significantly different in the 2 groups. In conclusion, the Han: SPRD Pkd model differs from human ADPKD to some extent. Uninephrectomy accelerates renal failure in the rat, but not in humans. On the other hand, in contrast to human ADPKD the renin system is suppressed in the rat model and ACE inhibition does not affect the course of renal failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7708256

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion.

Authors:  B K Yoder; W G Richards; C Sommardahl; W E Sweeney; E J Michaud; J E Wilkinson; E D Avner; R P Woychik
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease.

Authors:  Charles E Wiedmeyer; Angela B Royal
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

3.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

4.  Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2006-12       Impact factor: 1.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.